Thames Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bio-Rad Laboratories Class A
BIO
|
+$8.49M |
| 2 |
Entegris
ENTG
|
+$5.94M |
| 3 |
Salesforce
CRM
|
+$5.32M |
| 4 |
CWAN
Clearwater Analytics
CWAN
|
+$4.37M |
| 5 |
Monster Beverage
MNST
|
+$3.32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nasdaq
NDAQ
|
+$19.5M |
| 2 |
Ross Stores
ROST
|
+$12.5M |
| 3 |
Microsoft
MSFT
|
+$11.3M |
| 4 |
TJX Companies
TJX
|
+$11.2M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$9.01M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 56.88% |
| 2 | Financials | 19.49% |
| 3 | Healthcare | 11.47% |
| 4 | Consumer Discretionary | 6.08% |
| 5 | Industrials | 3.62% |
Similar funds
Thames Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Thames Capital Management held 31 positions worth $142M, down 33% from $211M the previous quarter. Its ten largest holdings account for 75% of the portfolio.
Thames Capital Management withdrew a net $86.4M in Q1 2023, closing 12 positions and reducing 7 holdings. Its most notable exit was Nasdaq, an estimated $19.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 57% of assets, up from 37% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Thames Capital Management opened a new position in Bio-Rad Laboratories Class A worth $8.69M.
- Thames Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 18,146 shares worth $8.69M.
- Thames Capital Management's biggest Q1 2023 reduction was Microsoft, cutting an estimated $11.3M.
- Thames Capital Management fully exited Nasdaq in Q1 2023, selling an estimated $19.5M.
- Thames Capital Management's ten largest holdings make up 75% of its $142M portfolio in Q1 2023.
- Thames Capital Management opened 7 new positions and closed 12 in Q1 2023.
- Thames Capital Management's portfolio value fell 33% quarter-over-quarter to $142M.
Based on Thames Capital Management's 13F filing for Q1 2023, filed 11 May 2023.